About MicrofluidX
MicrofluidX is a company based in London (United Kingdom) founded in 2018 by Antoine Espinet and Cesare Cejas. It operates as a D2C. MicrofluidX has raised $13.14 million across 6 funding rounds from investors including Esco Lifesciences, UK Research and Innovation and Cambridge Angels. The company has 10 employees as of March 31, 2022. MicrofluidX offers products and services including Cyto Engine. MicrofluidX operates in a competitive market with competitors including Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others.
- Headquarter London, United Kingdom
- Employees 10 as on 31 Mar, 2022
- Founders Antoine Espinet, Cesare Cejas
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Microfluidx Ltd
- Date of Incorporation 25 Oct, 2018
- Jurisdiction STEVENAGE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.14 M (USD)
in 6 rounds
-
Latest Funding Round
$867.61 K (USD), Grant
Dec 19, 2023
-
Investors
Esco Lifesciences
& 8 more
-
Employee Count
10
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MicrofluidX
MicrofluidX offers a comprehensive portfolio of products and services, including Cyto Engine.
Tool for cell analysis updates via website
People of MicrofluidX
Unlock access to complete
Funding Insights of MicrofluidX
MicrofluidX has successfully raised a total of $13.14M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $867.61 thousand completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MicrofluidX
MicrofluidX has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Esco Lifesciences, UK Research and Innovation and Cambridge Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage deeptech businesses are supported through venture capital investments.
|
Locked | Locked | Locked | |
|
Early-stage innovations are funded by UKI2S across key sectors.
|
Locked | Locked | Locked | |
|
Seed to growth stage investments focused venture capital and private equity firm based out of London
|
Locked | Locked | Locked |
Investor details for MicrofluidX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MicrofluidX
Investment portfolio details for MicrofluidX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MicrofluidX
Detailed financials for MicrofluidX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Microfluidx Comparisons
Peer comparison for MicrofluidX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MicrofluidX
MicrofluidX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal feed supplements are produced using proprietary fermentation technology.
|
|
| Locked | Locked | Locked |
Intensified biomanufacturing technologies for viral production are developed and manufactured.
|
|
| Locked | Locked | Locked |
Developer of sensor and integration technologies for continuous control and bioprocess automation
|
|
| Locked | Locked | Locked |
Intelligent fermentation services for industrial and synthetic biology are provided.
|
|
| Locked | Locked | Locked |
Modular bioreactors are developed for biotechnology research applications.
|
Detailed competitors of MicrofluidX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Microfluidx
Complete news archive for MicrofluidX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MicrofluidX
MicrofluidX was founded in 2018 and raised its 1st funding round 2 years after it was founded.
MicrofluidX is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Antoine Espinet is the current CEO of MicrofluidX. They have also founded this company.
MicrofluidX is a funded company, having raised a total of $13.14M across 6 funding rounds to date.
As of Mar 31, 2022, the latest employee count at MicrofluidX is 10.
MFX, previously MicrofluidX, is a company registered in England and Wales that focuses on providing updates for the Cyto Engine, likely a tool for cell analysis in biotech. They have rebranded and direct users to their new website for the latest information. The company engages in digital content delivery and maintains all rights reserved as of 2024, emphasizing innovation in healthcare tech.
MicrofluidX's top competitors include Unibio, Univercells Tech and Nirrin Technologies.
MicrofluidX offers Cyto Engine.
MicrofluidX has 9 investors. Key investors include Esco Lifesciences, UK Research and Innovation, Cambridge Angels, Longwall Ventures, and UKI2S.